GUARDIGLI, Gabriele
 Distribuzione geografica
Continente #
NA - Nord America 3.891
AS - Asia 2.331
EU - Europa 1.139
SA - Sud America 419
Continente sconosciuto - Info sul continente non disponibili 88
AF - Africa 72
OC - Oceania 11
Totale 7.951
Nazione #
US - Stati Uniti d'America 3.761
SG - Singapore 925
CN - Cina 511
BR - Brasile 337
IT - Italia 318
VN - Vietnam 277
HK - Hong Kong 189
DE - Germania 181
UA - Ucraina 146
GB - Regno Unito 105
BD - Bangladesh 101
TR - Turchia 81
FI - Finlandia 77
FR - Francia 75
JP - Giappone 66
CA - Canada 62
IN - India 55
SE - Svezia 47
RU - Federazione Russa 44
MX - Messico 41
AR - Argentina 32
NL - Olanda 28
ID - Indonesia 25
PL - Polonia 23
ZA - Sudafrica 23
ES - Italia 21
IQ - Iraq 20
CO - Colombia 18
LT - Lituania 15
MY - Malesia 11
PK - Pakistan 11
UZ - Uzbekistan 11
BE - Belgio 10
KE - Kenya 10
MA - Marocco 10
AT - Austria 9
EG - Egitto 9
PH - Filippine 9
AE - Emirati Arabi Uniti 8
VE - Venezuela 8
AU - Australia 7
BO - Bolivia 6
EC - Ecuador 6
SA - Arabia Saudita 6
TN - Tunisia 6
CR - Costa Rica 5
CZ - Repubblica Ceca 5
IE - Irlanda 5
JM - Giamaica 5
AL - Albania 4
CL - Cile 4
ET - Etiopia 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
BY - Bielorussia 3
CH - Svizzera 3
DZ - Algeria 3
PE - Perù 3
PY - Paraguay 3
SV - El Salvador 3
BB - Barbados 2
BW - Botswana 2
HN - Honduras 2
HU - Ungheria 2
JO - Giordania 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
LV - Lettonia 2
MN - Mongolia 2
NI - Nicaragua 2
PA - Panama 2
RO - Romania 2
SN - Senegal 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BZ - Belize 1
CU - Cuba 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
IL - Israele 1
IM - Isola di Man 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MW - Malawi 1
NG - Nigeria 1
Totale 7.854
Città #
Singapore 580
Ashburn 525
San Jose 330
Woodbridge 209
Santa Clara 205
Hong Kong 184
Chandler 169
Fairfield 166
Jacksonville 152
Council Bluffs 142
Beijing 141
Houston 130
New York 109
Ho Chi Minh City 92
Ann Arbor 88
Los Angeles 77
Hanoi 76
Wilmington 76
Seattle 71
Munich 70
Dallas 66
Tokyo 64
Milan 53
Nanjing 52
Cambridge 45
Princeton 44
Izmir 43
Lauterbourg 41
São Paulo 38
Helsinki 32
Shanghai 31
Boardman 28
Mexico City 28
Bologna 26
Toronto 26
Orem 25
San Diego 25
Phoenix 24
Buffalo 23
Chicago 23
Denver 22
Ferrara 22
London 21
Rome 20
Warsaw 20
Atlanta 19
Brooklyn 19
Bremen 18
Stockholm 17
Da Nang 16
Turku 16
Naples 15
The Dalles 15
Jakarta 14
Johannesburg 14
Shenyang 14
Chennai 13
Hefei 13
Montreal 12
Tashkent 11
Tianjin 11
Falls Church 10
Brussels 9
Düsseldorf 9
Haiphong 9
Nairobi 9
New Delhi 9
Poplar 9
Rio de Janeiro 9
San Francisco 9
Boston 8
Changsha 8
Dhaka 8
Jiaxing 8
Moscow 8
Nanchang 8
Nuremberg 8
Amsterdam 7
Belo Horizonte 7
Columbus 7
Dearborn 7
Figino 7
Florence 7
Hebei 7
Kuala Lumpur 7
Manchester 7
Miami 7
Sydney 7
Thái Nguyên 7
Acireale 6
Baghdad 6
Bogotá 6
Cairo 6
Falkenstein 6
Goiânia 6
Kunming 6
Ninh Bình 6
Paris 6
Redwood City 6
Addison 5
Totale 4.958
Nome #
High-dose BoluS TiRofibAn and Sirolimus eluting STEnt versus abiciximab and bare metal stent in acute MYocardial infarction (STRATEGY) study - Protocol design and demography of the first 100 patients 270
Reperfusion Damage - A Story of Success, Failure, and Hope 270
Tessuto adiposo epicardico quale nuovo fattore di rischio cardiovascolare 220
Assessment of left ventricular volume and function by integration of simplified 3D echocardiography, tissue harmonic imaging and automated extraction of endocardial borders 217
Improved recognition of dysfunctioning myocardial segments by longitudinal strain rate versus velocity in patients with myocardial infarction 214
EL PENSAMIENTO NARRATIVO PARA CONTRARRESTAR LAS ENFERMEDADES CARDIOVASCULARES. PRIMEROS RESULTADOS DE UN CAMINO DE PREVENCIÓN SECUNDARIA 214
The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty - The ADVANCE trial 206
Efficacy of angiotensin-converting enzyme inhibitors in secondary prevention 203
Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: An insight into the mechanisms of cardiac involvement 195
Tumor necrosis factor-α receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: The cytokine-activation and long-term prognosis in myocardial infarction (C-ALPHA) study 190
Heart Rate Variability Relates with Competition Performance in Professional Soccer Players 186
Bradykinin and coronary artery disease 185
The heart rate story 185
Secondary Prevention of CAD with ACE Inhibitors: A Struggle Between Life and Death of the Endothelium 182
Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients. 181
A modern fairy tale 180
In- and out-of-hospital mortality for myocardial infarction during the first wave of the COVID-19 pandemic in Emilia-Romagna, Italy: A population-based observational study 179
Multimodality imaging in acromegalic cardiomiopathy: a case report 176
Immune Checkpoint Inhibitors-Associated Myocarditis: Diagnosis, Treatment and Current Status on Rechallenge 176
Factor XIIIA-V34L and Factor XIIIB-H95R Gene Variants and Survival after Myocardial Infarction. 174
Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial 173
Pathophysiological role of heart rate: from ischaemia to left ventricular dysfunction 172
Oltre la dissincronia quali fattori determinano la risposta alla terapia di resincronizzazione cardiaca? 170
Procalcitonin Predicts Bacterial Infection, but Not Long-Term Occurrence of Adverse Events in Patients with Acute Coronary Syndrome 170
Screening della fibrillazione atriale nella popolazione generale: esperienza della campagna educazionale sul rischio cardiovascolare della Regione Emilia-Romagna [Screening for atrial fibrillation in the general population: experience from a cardiovascular risk campaign in the Emilia-Romagna Region] 168
Oxidative stress during myocardial ischaemia and heart failure 168
Angiotensin II overproduction: enemy of the vessel wall 166
CORRENTE IF COME NUOVO TARGET TERAPEUTICO NELL’ANGINA STABILE 164
CARDIOPROTECTION WITH ACE INHIBITORS: NON-ANGIOTENSIN II-RELATED MECHANISMS 160
Tirofiban: A critical reappraisal of the clinical use, recent developments and future perspectives 156
Three-Dimensional Electro-Anatomical Mapping and Myocardial Work Performance during Spontaneous Rhythm, His Bundle Pacing and Right Ventricular Pacing: The EMPATHY Study 155
A COVID-19 specific multiparametric and ECG-based score for the prediction of in-hospital mortality: ELCOVID score 154
Interventricular dyssynchrony does not identify CRT responders in patients with heart failure 150
Ferrara VI 150
Role of duration of post-stress left ventricular dysfunction in the identification of multivassel coronary artery disease: a Tc-99m sestamibi gated-SPECT study 148
Criteri di appropriatezza nella gestione della terapia ipocolesterolemizzante con alirocumab nel paziente ad alto rischio cardiovascolare. L’opinione di un gruppo multidisciplinare di esperti italiani [Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts] 138
FERRARA: CITTÀ DELLA PREVENZIONE 135
LEFT VENTRICULAR REMODELLING AT THE LIMITS 123
Ferrara II 118
Tirofiban, administered at high dose bolus during coronary angioplasty is highly effective in preventing periprocedural ischemic complications in diabetic patients. Insights into the ADVANCE trial. 115
ZERO FLUOROSCOPY CARDIAC ABLATION: A NOVEL WORKFLOW FOR ATRIAL FIBRILLATION 108
P299 WATCHMAN DEVICE THROMBOSIS FOLLOWING THE PERCUTANEOUS CLOSURE OF THE LEFT ATRIUM APPENDAGE: A "CUL–DE–SAC" IN THE ANTITHROMBOTIC STRATEGY 103
P422 CARDIOTOXICITY ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITORS: A CLINICAL CASE 101
P1 ATRIAL TACHYCARDIA IN PATIENT WITH TRANSFUSION–DEPENDENT BETA THALASSEMIA AND SEVERE HEMOCHROMATOSIS: A CASE REPORT 100
One-year outcome of elderly patients with endocarditis: a retrospective observational study 97
P18 ATRIAL FIBRILLATION IN BETA–THALASSAEMIA: PHYSIOPATHOLOGY AND CLINICAL MANAGEMENT 91
The future of cardiovascular prevention: between fiction and reality 81
Tricuspid annular plane systolic excursion to systolic pulmonary artery pressure ratio in Hypertrophic cardiomyopathy 76
null 61
Cardiovascular prevention: sometimes dreams can come true 56
Physical activity and cardiac rehabilitation after myocardial infarction: the risk of obtaining large benefits 21
Totale 7.951
Categoria #
all - tutte 37.060
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 576
Totale 37.636


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022298 0 0 22 11 18 18 15 20 14 25 34 121
2022/2023406 39 10 15 43 77 64 19 40 54 6 33 6
2023/2024277 18 37 10 4 13 47 20 23 4 8 14 79
2024/20251.285 23 35 85 63 158 125 43 52 262 122 170 147
2025/20263.765 393 153 274 470 562 253 376 231 332 391 223 107
2026/2027459 122 235 102 0 0 0 0 0 0 0 0 0
Totale 7.951